EUNUVY

DEAD

Serial Number

97485013

Owner

Sage Therapeutics, Inc.

Attorney

Steven A. Abreu

Filing Date

Jul 1, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

EUNUVY Trademark

Serial Number: 97485013

EUNUVY is a trademark filed by Sage Therapeutics, Inc. on July 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Sage Therapeutics, Inc. (42 trademarks)

215 First Street
Cambridge, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

Steven A. Abreu

1,762 trademarks filed View all →

Correspondence Address

Steven A. Abreu SUNSTEIN LLP

100 HIGH STREET

BOSTON, MA 02110

United States

Trademark Details

Filing Date

July 1, 2022

Registration Date

Not Registered

Published for Opposition

July 1, 2025

Goods & Services

pharmaceutical preparations for the treatment of epilepsy, essential tremors, Parkinson's disease, epileptiform disorders, Huntington's disease, Alzheimer's, dementia, GABA hypofunction, and NMDA hypofunction; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Mar 30, 2026 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Mar 30, 2026 ABN6

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 26, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 1, 2025 NPUB

PUBLISHED FOR OPPOSITION

Jul 1, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 25, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 28, 2025 CNSA

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Nov 20, 2024 RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jan 11, 2024 RCSC

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jul 14, 2023 GNS3

LETTER OF SUSPENSION E-MAILED

Jul 14, 2023 GNSL

SUSPENSION LETTER WRITTEN

Jul 14, 2023 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 7, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 7, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 7, 2023 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Apr 5, 2023 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Apr 5, 2023 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 10, 2023 GNRN

NON-FINAL ACTION E-MAILED

Jan 10, 2023 GNRT

NON-FINAL ACTION WRITTEN

Jan 10, 2023 CNRT

ASSIGNED TO EXAMINER

Jan 3, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 21, 2022 NWOS

NEW APPLICATION ENTERED

Jul 5, 2022 NWAP

Related Trademarks

More from this Owner

SAGE THERAPEUTICS

Serial #98915590

More in Same Class

SANOFI